Breast Cancer (Triple Negative) Related Human Specimens
58 Breast Cancer (Triple Negative) Patients
Note: The majority of patients have donated multiple samples.
Frozen samples:
48
FFPE samples:
53
DNA samples:
2
On the REPROCELL blog
Latest in Drug Discovery
.jpg?width=756&height=425&name=New%20Approach%20Methodologies%20(NAMs).jpg)
The Resurgence of New Approach Methodologies (NAMs) in Drug Discovery and Safety Assessment
Explore how New Approach Methodologies are revolutionizing drug discovery and safety assessment by enhancing human-relevant research and reducing reliance on animal testing.
30 April 2026
Mapping the Competitive Landscape of Human Tissue-Based Drug Discovery
Explore how REPROCELL leads in human tissue-based drug discovery, addressing market gaps and offering innovative, disease-relevant solutions for better therapeutic outcomes.
02 April 2026
Donor Variability in Ex Vivo Human Tissue Studies: Challenge, Feature, or Translational Advantage
Explore how donor variability in ex vivo human tissue studies enhances translational research by providing insights into patient heterogeneity and improving drug discovery.
12 March 2026